메뉴 건너뛰기




Volumn 9, Issue 6, 2008, Pages 717-718

Pergolide and valvular heart disease: The lower the better?

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DOPAMINE; PERGOLIDE;

EID: 54949083123     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen202     Document Type: Editorial
Times cited : (7)

References (12)
  • 1
    • 11144354035 scopus 로고    scopus 로고
    • Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
    • Van Camp G, Flamez A, Cosyns B, Weytjens C, Muyldermans L, Van Zandijcke M et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004;363:1179-83.
    • (2004) Lancet , vol.363 , pp. 1179-1183
    • Van Camp, G.1    Flamez, A.2    Cosyns, B.3    Weytjens, C.4    Muyldermans, L.5    Van Zandijcke, M.6
  • 4
    • 33846017361 scopus 로고    scopus 로고
    • Drugs and valvular heart disease
    • Roth BL. Drugs and valvular heart disease. N Engl J Med 2007;356:6-9.
    • (2007) N Engl J Med , vol.356 , pp. 6-9
    • Roth, B.L.1
  • 5
    • 30344481661 scopus 로고    scopus 로고
    • Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease
    • Muraki M, Mikami T, Kitaguchi M, Sugawara T, Isonishi K, Kaneko S et al. Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease. J Cardiol 2005;46:221-7.
    • (2005) J Cardiol , vol.46 , pp. 221-227
    • Muraki, M.1    Mikami, T.2    Kitaguchi, M.3    Sugawara, T.4    Isonishi, K.5    Kaneko, S.6
  • 6
    • 33748363728 scopus 로고    scopus 로고
    • Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
    • Kim JY, Chung EJ, Park SW, Lee WY. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Mov Disord 2006;21:1261-4.
    • (2006) Mov Disord , vol.21 , pp. 1261-1264
    • Kim, J.Y.1    Chung, E.J.2    Park, S.W.3    Lee, W.Y.4
  • 7
    • 36348942365 scopus 로고    scopus 로고
    • Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide
    • Ruzicka E, Linkova H, Penicka M, Ulmanova O, Novakova L, Roth J. Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide. J Neurol 2007;254:1575-8.
    • (2007) J Neurol , vol.254 , pp. 1575-1578
    • Ruzicka, E.1    Linkova, H.2    Penicka, M.3    Ulmanova, O.4    Novakova, L.5    Roth, J.6
  • 11
    • 34948817624 scopus 로고    scopus 로고
    • In vivo model of drug-induced valvular heart disease in rats: Pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology
    • Droogmans S, Franken PR, Garbar C, Weytjens C, Cosyns B, Lahoutte T et al. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. Eur Heart J 2007;28:2156-62.
    • (2007) Eur Heart J , vol.28 , pp. 2156-2162
    • Droogmans, S.1    Franken, P.R.2    Garbar, C.3    Weytjens, C.4    Cosyns, B.5    Lahoutte, T.6
  • 12
    • 21644477054 scopus 로고    scopus 로고
    • Pergolide associated valvulopathy: Critical analysis of the literature and practical recommendations
    • Corvol JC, Schupbach M, Bonnet AM. Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations. Rev Neurol (Paris) 2005;161:637-43.
    • (2005) Rev Neurol (Paris) , vol.161 , pp. 637-643
    • Corvol, J.C.1    Schupbach, M.2    Bonnet, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.